Biolidics to launch Covid-19 rapid test kit in April

Singapore

CANCER-diagnostics company Biolidics on Monday announced that it has launched a rapid test kit for Covid-19, which is expected to be available by the end of April.

Biolidics said its novel corona-virus test can detect Covid-19 using serum, plasma or whole blood samples with an accuracy of more than 95 per cent in 10 minutes, and has received provisional authorisation from Singapore's Health Sciences Authority for use here.